MGTX: MeiraGTx Holdings plc
Performance
MGTX +12.04%
Watchlist
Select an item
Summary
MGTX at a glance
MGTX returned +12.04% over the past year and -14.39% a year over five years. Its worst drop in that year was -43.15%, smaller than 32% of stocks on Redstone, and its Sharpe ratio of 0.42 beats 46% of stocks on Redstone. It pays no dividends.
Current Drawdown
-36.61%
Rolling Volatility
66.86%
Actions
Metrics
Risk Indicators
Alpha8.31%
Beta1.68x
Sharpe0.42
Sortino0.63
Omega1.07
Calmar0.28
Martin1.45
Profile
About MGTX
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy.
- Sector
- Health Care
- Industry
- Biological Products, (no Diagnostic Substances)
- Market cap
- $911M
- Listed
- Jun 2018
- Employees
- 393
- Headquarters
- New York, NY
- Website
- meiragtx.com
Comparisons